VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,270,450 | +18.0% | 1,255,000 | +21.6% | 0.03% | +14.8% |
| Q1 2023 | $7,006,329 | -2.8% | 1,031,860 | +5.8% | 0.03% | -3.6% |
| Q4 2022 | $7,207,171 | -22.3% | 975,260 | +3.8% | 0.03% | -30.0% |
| Q3 2022 | $9,279,000 | -5.6% | 939,190 | +4.2% | 0.04% | +2.6% |
| Q2 2022 | $9,829,000 | -4.8% | 901,730 | -1.2% | 0.04% | +18.2% |
| Q1 2022 | $10,320,000 | +21.0% | 912,460 | +67.8% | 0.03% | +22.2% |
| Q4 2021 | $8,530,000 | +91.9% | 543,690 | +109.6% | 0.03% | +92.9% |
| Q3 2021 | $4,446,000 | -21.5% | 259,420 | -1.5% | 0.01% | -17.6% |
| Q2 2021 | $5,664,000 | +55.3% | 263,300 | +8.4% | 0.02% | +54.5% |
| Q1 2021 | $3,647,000 | +4.1% | 242,800 | -8.9% | 0.01% | -8.3% |
| Q4 2020 | $3,502,000 | – | 266,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |